IMUC — Eom Pharmaceutical Holdings Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $9.95m
- $11.79m
Annual balance sheet for Eom Pharmaceutical Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2015 December 31st | 2016 December 31st | 2017 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | PROSPECTUS/A | PROSPECTUS/A |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 22.6 | 11.4 | 6.63 | 0.263 | 1.49 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 24.6 | 13.4 | 7.01 | 0.263 | 1.67 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.181 | 0.11 | 0.001 | — | — |
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 30.1 | 16.9 | 7.01 | 0.267 | 1.67 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Current Liabilities | 2.27 | 3.24 | 2.36 | 0.137 | 0.465 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 8.36 | 10.8 | 2.36 | 0.137 | 3.28 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 21.7 | 6.13 | 4.65 | 0.13 | -1.62 |
Total Liabilities & Shareholders' Equity | 30.1 | 16.9 | 7.01 | 0.267 | 1.67 |
Total Common Shares Outstanding |